SCHEMBL5114928

SCHEMBL5114928

Oc1ccc2c(c1)CCN(C1CCCC1)C2Cc1ccc(OCCC2CCCCN2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 13/20 0.40
ESR2 Q92731 13/20 0.40
GRIN2B Q13224 2/20 0.40
MLNR O43193 1/20 0.39
NR1I2 O75469 1/20 0.39
NR3C1 P04150 1/20 0.39
CHRM2 P08172 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRA2A P08913 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
CHRM1 P11229 1/20 0.39
DRD2 P14416 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
CHRM3 P20309 1/20 0.39
SLC6A2 P23975 1/20 0.39
NPY1R P25929 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
AVPR2 P30518 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5109392 0.99 ESR1 (0.40) ESR1ESR2GRIN2BMLNRNR1I2
SCHEMBL5116826 0.94 ESR1 (0.38) ESR1ESR2GRIN2BMLNRNR1I2
Trifluoroacetic Acid SCHEMBL5113798 0.93 ESR1 (0.43) ESR1ESR2GRIN2BMLNRNR1I2
Trifluoroacetic Acid SCHEMBL5108860 0.92 ESR1 (0.42) ESR1ESR2GRIN2BMLNRNR1I2
SCHEMBL5103000 0.90 BCHE (0.41) DRD2
SCHEMBL5102397 0.89 BCHE (0.42) DRD2HRH3
SCHEMBL5115570 0.89 KDM4E (0.48) ESR1ESR2GRIN2BDRD2KCNH2
Trifluoroacetic Acid SCHEMBL5114107 0.88 ESR1 (0.40) ESR1ESR2GRIN2BMLNRNR1I2
SCHEMBL5113793 0.87 ESR1 (0.37) ESR1ESR2SLC6A2ADRA1AOPRK1
SCHEMBL5108854 0.86 ESR1 (0.36) ESR1ESR2SLC6A2ADRA1AOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7435729-B2 Compounds and methods for modulation of estrogen receptors SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-14 US disclosed
EP-1322617-A1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARMACEUTICALS, INC. (US) 2003-07-02 EP disclosed
WO-2002024653-A1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARMACEUTICALS, INC. (US) 2002-03-28 WO disclosed